GleamWall
中文EN

ACH ACCENDRA HEALTH INC/VA/

Wholesale-Medical, Dental & Hospital Equipment & Supplies · OTC · SEC CIK 75252 · Fiscal year ends 12/31

Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.0%
TTM net income YoY-195.8%
TTM EPS YoY-195.6%
Revenue 3-yr CAGR-35.4%
Net income 3-yr CAGR—

Margins

Gross margin46.0%
Operating margin0.9%
Net margin-39.8%
FCF margin-10.7%
EBITDA margin8.2%

Returns

ROE-2,037.6%
ROA-29.8%
ROIC (approx.)1.0%
Asset turnover0.75x

Leverage & solvency

Liabilities / assets119.2%
Debt / equity—
Current ratio0.49x
Interest coverage0.22x

Cash quality & payout

Operating cash flow / net income0.11x
Accruals ratio-26.5%
Payout ratio—
Capex / revenue6.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$601.77M$613.23M$627.78M$708.97M$697.26M$681.92M$673.88M$695.02M
Cost of revenue$340.47M$349.83M$349.75M$385.71M$375.07M$357.31M$354.64M$362.03M
Gross profit$261.31M$263.41M$278.03M$323.26M$322.20M$324.60M$526.01M$579.77M
SG&A expense$249.46M$243.56M$255.23M$271.50M$265.84M$267.85M$262.37M$269.89M
Operating income$1.33M-$35.15M$17.12M$20.91M$26.47M-$39.71M$19.79M-$272.70M
Interest expense$37.62M$34.54M$32.35M$27.93M$29.03M$26.01M$24.21M$27.62M
Pretax income-$36.82M-$87.63M-$16.25M-$7.97M-$3.63M-$84.95M-$5.40M-$302.04M
Income tax-$18.86M$1.44M-$9.78M$1.47M$1.97M-$1.13M-$1.59M$29.82M
Net income-$19.70M-$89.07M-$6.47M-$56.33M-$150.28M-$869.06M-$24.98M-$296.12M
EBITDA$40.25M$30.55M$78.87M$50.78M$90.57M$3.28M$62.69M-$207.51M
EPS (basic)-0.25-1.16-0.08—-1.94-11.30-0.32—
EPS (diluted)-0.25-1.16-0.08—-1.94-11.30-0.32—
Weighted avg. shares (diluted)76.91M76.69M76.43M—77.29M76.94M77.27M—
Balance sheet
Cash & equivalents$26.61M$7.65M$336.88M$281.99M$32.84M$38.26M$59.44M$27.57M
Inventory$82.10M$73.34M$65.28M$74.44M$63.85M$69.23M$1.41B$67.58M
Current assets$273.92M$271.45M$588.50M$547.87M$2.13B$2.30B$2.21B$2.02B
PP&E, net$218.24M$208.67M$227.73M$256.16M$259.73M$259.30M$520.33M$249.28M
Goodwill$1.23B$1.23B$1.23B$1.23B$1.23B$1.23B$1.33B$1.23B
Intangibles$73.03M$78.01M$107.24M$136.47M$165.69M$194.92M$285.09M$210.06M
Total assets$2.08B$2.11B$2.42B$2.45B$4.04B$4.15B$4.86B$4.66B
Current liabilities$671.50M$666.22M$1.20B$947.08M$2.47B$2.67B$1.96B$1.85B
Short-term debt$35.00M$0$581.25M$250.00M$280.00M$383.00M$49.95M$42.87M
Long-term debt$1.72B$1.72B$1.52B$1.80B$1.84B$1.59B$1.90B$1.80B
Total debt$1.75B$1.72B$2.10B$2.05B$2.12B$1.98B$1.95B$1.84B
Total liabilities$2.65B$2.66B$2.88B$2.91B$4.47B$4.44B$4.29B$4.07B
Shareholders' equity-$568.23M-$550.94M-$464.76M-$460.98M-$429.51M-$281.01M$570.98M$586.36M
Net debt$1.73B$1.71B$1.77B$1.77B$2.08B$1.94B$1.89B$1.81B
Shares outstanding76.92M76.91M76.58M76.39M77.30M77.20M77.22M77.20M
Cash flow statement
Operating cash flow-$17.41M-$26.01M-$50.08M$68.19M-$172.52M$37.61M-$35.07M$71.00M
Capital expenditure$39.16M$47.59M$41.65M$13.13M$42.13M$77.78M$45.79M$22.25M
Free cash flow-$56.58M-$73.59M-$91.72M$55.05M-$214.65M-$40.17M-$80.86M$48.75M
Investing cash flow$5.77M-$31.25M$53.92M$285.00M-$39.46M-$52.92M-$48.20M-$52.30M
Financing cash flow$30.60M-$271.98M$51.08M-$117.50M$181.10M$31.70M$92.78M-$43.10M
Depreciation & amortization$38.92M$65.70M$61.74M$29.87M$64.10M$42.99M$42.90M$65.19M
Stock-based compensation$2.11M$4.00M$3.09M-$4.46M-$168,000$4.87M$4.42M$7.55M
Share buybacks——$0$3.52M$0$5.15M$1.50M—

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.